Association of Advanced Lipoprotein Subpopulation Profiles with Insulin Resistance and Inflammation in Patients with Type 2 Diabetes Mellitus
Authors:
- Ahmed BakillahAhmed Bakillah
- Khamis Khamees ObeidKOKhamis Khamees Obeid
- Maram Al SubaieeMSMaram Al Subaiee
- Ayman Farouk SolimanASAyman Farouk Soliman
- Mohammad Al ArabMAMohammad Al Arab
- Shahinaz Faisal BashirShahinaz Faisal Bashir
- Arwa Al HussainiAHArwa Al Hussaini
- Abeer Al OtaibiAOAbeer Al Otaibi
- Sindiyan Al Shaikh MubarakSMSindiyan Al Shaikh Mubarak
- Jahangir IqbalJIJahangir Iqbal
- Ali Ahmed Al QarniAQAli Ahmed Al Qarni
Open Access
- 6 January 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 487
Abstract
Plasma lipoproteins exist as several subpopulations with distinct particle number and size that are not fully reflected in the conventional lipid panel. In this study, we sought to quantify lipoprotein subpopulations in patients with type 2 diabetes mellitus (T2DM) to determine whether specific lipoprotein subpopulations are associated with insulin resistance and inflammation markers. The study included 57 patients with T2DM (age, 61.14 ± 9.99 years; HbA1c, 8.66 ± 1.60%; mean body mass index, 35.15 ± 6.65 kg/m2). Plasma lipoprotein particles number and size were determined by nuclear magnetic resonance spectroscopy. Associations of different lipoprotein subpopulations with lipoprotein insulin resistance (LPIR) score and glycoprotein acetylation (GlycA) were assessed using multi-regression analysis. In stepwise regression analysis, VLDL and HDL large particle number and size showed the strongest associations with LPIR (R2 = 0.960; p = 0.0001), whereas the concentrations of the small VLDL and HDL particles were associated with GlycA (R2 = 0.190; p = 0.008 and p = 0.049, respectively). In adjusted multi-regression analysis, small and large VLDL particles and all sizes of lipoproteins independently predicted LPIR, whereas only the number of small LDL particles predicted GlycA. Conventional markers HbA1c and Hs-CRP did not exhibit any significant association with lipoprotein subpopulations. Our data suggest that monitoring insulin resistance-induced changes in lipoprotein subpopulations in T2DM might help to identify novel biomarkers that can be useful for effective clinical intervention.Keywords
Funding Information
- King Abdullah International Medical Research Center (KAIMRC) (RA-18/021A (PI: Ahmed Bakillah))
This publication has 70 references indexed in Scilit:
- Small, Dense LDL Particles Predict Changes in Intima Media Thickness and Insulin Resistance in Men with Type 2 Diabetes and Prediabetes – A Prospective Cohort StudyPLOS ONE, 2013
- Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemiaProgress in Nuclear Magnetic Resonance Spectroscopy, 2013
- Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in WomenDiabetes, 2010
- Advanced Lipoprotein Testing and Subfractionation Are Clinically UsefulCirculation, 2009
- Dyslipidemia in type 2 diabetes mellitusNature Reviews Endocrinology, 2009
- Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in WomenCirculation, 2009
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Combined Effects of Hemoglobin A 1c and C-Reactive Protein on the Progression of Subclinical Carotid AtherosclerosisStroke, 2006
- Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis StudyCirculation, 2005
- Dyslipidemia and inflammation: an evolutionary conserved mechanismClinical Nutrition, 2005